Treatment with liraglutide for type 2 diabetes was not associated with an increased risk for hospitalization for heart failure (HF) or cardiovascular death in patients with vs without a history of HF.
Exercise may bring a wide range of benefits to adult and pediatric patients with Fontan circulation.
Emergency Medical Services personnel implement a broad spectrum of approaches to out-of-hospital cardiac arrest.
The promotion of arrhythmias in myocytes by mesenchymal stromal cells isolated from failing human hearts, which were found to produce high levels of interleukin-6 (IL-6), was abated in the presence of anti-IL-6 monoclonal antibodies.
Time to telemedicine diagnosis was found to be a useful parameter in assessing the effectiveness of telemedicine in patients who have experienced myocardial infarction.
The estimation of myocardial flow reserve using positron emission tomography may help identify patients with ischemic heart failure who would have improved outcomes with early coronary artery bypass grafting vs percutaneous coronary intervention.
Aboriginal and Torres Strait Islander status may predict death in individuals with acute coronary syndrome.
The Food and Drug Administration approved the 50cc temporary Total Artificial Heart System developed and manufactured by SynCardia Systems, LLC as a bridge to heart transplant for patients who are at imminent risk for death from biventricular failure.
Multisociety Lifelong Learning Statement focuses on learning competencies necessary for advanced heart failure and transplant cardiology specialists.
Patients with cardiovascular disease diagnosed with novel coronavirus (COVID-19) are urged to continue taking their angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) medications as prescribed.
